2024
Chapter 30 The emerging genetic landscape of renal cell carcinoma
Lee G, Shinder B, Sadimin E, Stephenson R, Singer E. Chapter 30 The emerging genetic landscape of renal cell carcinoma. 2024, 447-460. DOI: 10.1016/b978-0-12-822824-1.00035-3.ChaptersRenal cell carcinomaCell carcinomaOrgan-confined renal cell carcinomaKidney cancerMetastatic renal cell carcinomaLong-term survival outcomesLandscape of renal cell carcinomaDiagnosis of kidney cancerRenal tubule epithelial cellsTubule epithelial cellsGroup of diseasesSurgical resectionSystemic therapyDistant metastasisSurvival outcomesDiagnosed patientsEpithelial cellsPatientsPatient deathGenetic landscapeCarcinomaDiseaseCancerResectionMetastasis
2023
Predictive Biomarkers in Advanced Renal Cell Carcinoma
Shinder B, Kronstedt S, Hakimi A. Predictive Biomarkers in Advanced Renal Cell Carcinoma. 2023, 251-268. DOI: 10.1007/978-3-031-40901-1_11.ChaptersRenal cell carcinomaAdvanced renal cell carcinomaCell carcinomaPredictive biomarkersEra of treatment optionsCharacteristics of renal cell carcinomaPrediction of treatment responseOptimal therapeutic pathwayTargeted systemic therapyImmuno-oncology agentsRoutine clinical useSystemic therapyAdvanced diseaseClinical benefitTreatment responseTreatment optionsClinical useTherapeutic pathwaysCarcinomaPatientsBiomarkersMolecular characteristicsTherapyChromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
Lichtbroun B, Shinder B, Sara T, Srivastava A, Saraiya B, Mayer T, Cristelli R, Sadimin E, Weiss R, Singer E. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation. Journal Of Kidney Cancer And VHL 2023, 10: 1-8. PMID: 37441361, PMCID: PMC10334999, DOI: 10.15586/jkcvhl.v10i3.254.Peer-Reviewed Case Reports and Technical NotesChromophobe renal cell carcinomaSarcomatoid differentiationRenal cell carcinomaCell carcinomaClinical courseCases of ChRCCSystemic treatment optionsAggressive clinical courseMetastatic diseaseOverall survivalFavorable prognosisLarger tumorsClinicopathological dataPoor prognosisTreatment optionsPoor outcomeKidney cancerChRCCCarcinomaPrognosisDifferentiationSarcomatoidChromophobeTumorPatients
2022
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma
Patel HV, Kim S, Srivastava A, Shinder BM, Sterling J, Saraiya B, Mayer TM, Ghodoussipour S, Jang TL, Singer EA. Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2022, 20: 296-296.e9. PMID: 35105510, PMCID: PMC9149103, DOI: 10.1016/j.clgc.2022.01.001.Peer-Reviewed Original ResearchConceptsStage IV RCCMetastatic renal cell carcinomaNational Cancer DatabasePalliative interventionsRenal cell carcinomaMetastatic RCCClinical factorsCell carcinomaMultivariable logistic regression modelComprehensive cancer programsQuality of lifeLogistic regression modelsSarcomatoid histologyAdvanced malignanciesOverall cohortHigher education statusOncologic careInsurance statusCancer DatabaseCancer programsEarly initiationIntervention utilizationTreatment-specific mannerPatientsPI use
2021
MP19-08 DISPARITIES IN CLINICAL TRIAL PARTICIPATION FOR PATIENTS WITH RENAL CELL CARCINOMA AND PROSTATE CANCER
Shinder B, Kim S, Patel H, Mayer T, Saraiya B, Jang T, Kim I, Singer E. MP19-08 DISPARITIES IN CLINICAL TRIAL PARTICIPATION FOR PATIENTS WITH RENAL CELL CARCINOMA AND PROSTATE CANCER. Journal Of Urology 2021, 206: e330-e330. DOI: 10.1097/ju.0000000000002004.08.Peer-Reviewed Original Research
2017
Management of Postradical Prostatectomy Urinary Incontinence: A Review
Radadia K, Farber N, Shinder B, Polotti C, Milas L, Tunuguntla H. Management of Postradical Prostatectomy Urinary Incontinence: A Review. Urology 2017, 113: 13-19. PMID: 29031841, DOI: 10.1016/j.urology.2017.09.025.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPelvic floor muscle trainingTransurethral bulking agentsArtificial urinary sphincterTreat overactive bladderPostprostatectomy urinary incontinenceQuality of life of patientsDetrusor hypocontractilityMale slingRadical prostatectomyStress incontinenceOveractive bladderSphincter incompetenceUrinary sphincterOverflow incontinenceUrinary incontinenceTreatment modalitiesLife of patientsEfficacious optionMuscle trainingIncontinenceSuccess ratePatientsTreatmentBulking agentsProstatectomyBowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients.
Farber N, Davis R, Grimsby G, Shinder B, Cannon G, Jacobs M, Ost M, Schneck F, Stephany H, Gargollo P, Dwyer M. Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients. Canadian Journal Of Urology 2017, 24: 9038-9042. PMID: 28971794.Peer-Reviewed Original ResearchConceptsMechanical bowel preparationReconstructive urologic surgeryBowel preparationUrological surgeryPostoperative complicationsPerioperative measuresStatistically significant differencePostoperative outcomesPediatric patientsMyelomeningocele patientsSignificant differencePreoperative mechanical bowel preparationPreoperative bowel preparationStandard of careAugmentation cystoplastyComplication rateUrinary diversionNo significant differenceRandomized studyPatient populationOperative timeSurgeryComplicationsPatientsMyelomeningocelePerforming all major surgical procedures robotically will prolong wait times for surgery
Shinder BM, Farber NJ, Weiss RE, Jang TL, Kim IY, Singer EA, Elsamra SE. Performing all major surgical procedures robotically will prolong wait times for surgery. Robotic Surgery Research And Reviews 2017, 4: 87-91. PMID: 28890901, PMCID: PMC5586216, DOI: 10.2147/rsrr.s135713.Peer-Reviewed Original ResearchMajor surgical proceduresFellowship-trained surgeonsUrologic oncology proceduresHealth care systemRadical nephrectomyNumber of prostatectomiesSingle institutionTime patientsPartial nephrectomySurgery timeSurgical proceduresSurgical casesOncology proceduresNumber of casesSurgeryRobotic proceduresSurgical fieldMost hospitalsCare systemSurgeonsNumber of daysRS timeNephrectomyPatientsCalendar yearSurgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
Shinder B, Rhee K, Farrell D, Farber N, Stein M, Jang T, Singer E. Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach. Frontiers In Oncology 2017, 7: 107. PMID: 28620578, PMCID: PMC5449498, DOI: 10.3389/fonc.2017.00107.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMetastatic renal cell carcinomaRenal cell carcinomaSystemic therapyCell carcinomaSurgical managementSurgical management of patientsImmune checkpoint inhibitorsNeoadjuvant systemic therapyMetastatic kidney cancerCytokine-based immunotherapyOptimal patient selectionManagement of patientsCheckpoint inhibitorsCytoreductive surgeryMetastatic diseasePrimary tumorAdjuvant therapyProspective trialsTherapeutic armamentariumPatient selectionKidney cancerTherapyCarcinomaSurgeryPatients